309 related articles for article (PubMed ID: 27096746)
1. Design of Peptide Substrate for Sensitively and Specifically Detecting Two Aβ-Degrading Enzymes: Neprilysin and Angiotensin-Converting Enzyme.
Chen PT; Chen CL; Lin LT; Lo CH; Hu CJ; Chen RP; Wang SS
PLoS One; 2016; 11(4):e0153360. PubMed ID: 27096746
[TBL] [Abstract][Full Text] [Related]
2. A highly sensitive peptide substrate for detecting two Aß-degrading enzymes: neprilysin and insulin-degrading enzyme.
Chen PT; Liao TY; Hu CJ; Wu ST; Wang SS; Chen RP
J Neurosci Methods; 2010 Jun; 190(1):57-62. PubMed ID: 20435063
[TBL] [Abstract][Full Text] [Related]
3. Changes with age in the activities of beta-secretase and the Abeta-degrading enzymes neprilysin, insulin-degrading enzyme and angiotensin-converting enzyme.
Miners JS; van Helmond Z; Kehoe PG; Love S
Brain Pathol; 2010 Jul; 20(4):794-802. PubMed ID: 20175776
[TBL] [Abstract][Full Text] [Related]
4. Aggregation and catabolism of disease-associated intra-Abeta mutations: reduced proteolysis of AbetaA21G by neprilysin.
Betts V; Leissring MA; Dolios G; Wang R; Selkoe DJ; Walsh DM
Neurobiol Dis; 2008 Sep; 31(3):442-50. PubMed ID: 18602473
[TBL] [Abstract][Full Text] [Related]
5. Aβ-degrading enzymes: potential for treatment of Alzheimer disease.
Miners JS; Barua N; Kehoe PG; Gill S; Love S
J Neuropathol Exp Neurol; 2011 Nov; 70(11):944-59. PubMed ID: 22002425
[TBL] [Abstract][Full Text] [Related]
6. Heterologous amyloid seeding: revisiting the role of acetylcholinesterase in Alzheimer's disease.
Jean L; Thomas B; Tahiri-Alaoui A; Shaw M; Vaux DJ
PLoS One; 2007 Jul; 2(7):e652. PubMed ID: 17653279
[TBL] [Abstract][Full Text] [Related]
7. Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.
Jha NK; Jha SK; Kumar D; Kejriwal N; Sharma R; Ambasta RK; Kumar P
J Alzheimers Dis; 2015; 48(4):891-917. PubMed ID: 26444774
[TBL] [Abstract][Full Text] [Related]
8. Insulin-signaling Pathway Regulates the Degradation of Amyloid β-protein via Astrocytes.
Yamamoto N; Ishikuro R; Tanida M; Suzuki K; Ikeda-Matsuo Y; Sobue K
Neuroscience; 2018 Aug; 385():227-236. PubMed ID: 29932983
[TBL] [Abstract][Full Text] [Related]
9. Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain.
Wang S; Wang R; Chen L; Bennett DA; Dickson DW; Wang DS
J Neurochem; 2010 Oct; 115(1):47-57. PubMed ID: 20663017
[TBL] [Abstract][Full Text] [Related]
10. Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases?
Carson JA; Turner AJ
J Neurochem; 2002 Apr; 81(1):1-8. PubMed ID: 12067222
[TBL] [Abstract][Full Text] [Related]
11. Powering Amyloid Beta Degrading Enzymes: A Possible Therapy for Alzheimer's Disease.
Sikanyika NL; Parkington HC; Smith AI; Kuruppu S
Neurochem Res; 2019 Jun; 44(6):1289-1296. PubMed ID: 30806879
[TBL] [Abstract][Full Text] [Related]
12. Neprilysin-2 is an important β-amyloid degrading enzyme.
Hafez D; Huang JY; Huynh AM; Valtierra S; Rockenstein E; Bruno AM; Lu B; DesGroseillers L; Masliah E; Marr RA
Am J Pathol; 2011 Jan; 178(1):306-12. PubMed ID: 21224067
[TBL] [Abstract][Full Text] [Related]
13. Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.
Tayler H; Fraser T; Miners JS; Kehoe PG; Love S
J Alzheimers Dis; 2010; 22(4):1363-73. PubMed ID: 20930272
[TBL] [Abstract][Full Text] [Related]
14. The effect of amyloid associated proteins on the expression of genes involved in amyloid-β clearance by adult human astrocytes.
Mulder SD; Veerhuis R; Blankenstein MA; Nielsen HM
Exp Neurol; 2012 Jan; 233(1):373-9. PubMed ID: 22101005
[TBL] [Abstract][Full Text] [Related]
15. Neprilysin degrades murine Amyloid-β (Aβ) more efficiently than human Aβ: Further implication for species-specific amyloid accumulation.
Becker M; Moore A; Naughton M; Boland B; Siems WE; Walther T
Neurosci Lett; 2018 Nov; 686():74-79. PubMed ID: 30144539
[TBL] [Abstract][Full Text] [Related]
16. Differential cerebral deposition of IDE and NEP in sporadic and familial Alzheimer's disease.
Dorfman VB; Pasquini L; Riudavets M; López-Costa JJ; Villegas A; Troncoso JC; Lopera F; Castaño EM; Morelli L
Neurobiol Aging; 2010 Oct; 31(10):1743-57. PubMed ID: 19019493
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's Aβ
Leite JP; Gales L
FEBS Lett; 2019 Jan; 593(1):128-137. PubMed ID: 30403288
[TBL] [Abstract][Full Text] [Related]
18. New Insights into Epigenetic and Pharmacological Regulation of Amyloid-Degrading Enzymes.
Nalivaeva NN; Belyaev ND; Turner AJ
Neurochem Res; 2016 Mar; 41(3):620-30. PubMed ID: 26376806
[TBL] [Abstract][Full Text] [Related]
19. The antioxidant xanthorrhizol prevents amyloid-β-induced oxidative modification and inactivation of neprilysin.
Lim CS; Han JS
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29330223
[TBL] [Abstract][Full Text] [Related]
20. Degradation of Alzheimer's Amyloid-β by a Catalytically Inactive Insulin-Degrading Enzyme.
Sahoo BR; Panda PK; Liang W; Tang WJ; Ahuja R; Ramamoorthy A
J Mol Biol; 2021 Jun; 433(13):166993. PubMed ID: 33865867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
